MedTrace Logo

Postoperative VEGF and Recurrence After Colon Cancer Surgery

NCT04851054 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 280

Last updated 2021-04-20

No results posted yet for this study

Summary

The purpose of this trial is to study the relationship between the angiogenic response to surgical aggression, determined through the serum levels of vascular endothelial growth factor (VEGF) on postoperative day four, and the tumor recurrence in patients with colon cancer operated with a curative intention.

Conditions

  • Angiogenesis
  • Colon Cancer
  • Surgery
  • Recurrence
  • VEGF Overexpression

Interventions

PROCEDURE

Surgery for colon cancer with intention to cure

Surgery by open or laparoscopic approach

Sponsors & Collaborators

  • Germans Trias i Pujol Hospital

    collaborator OTHER

  • Hospital de Granollers

    collaborator OTHER

  • Althaia Xarxa Assistencial Universitària de Manresa

    collaborator OTHER

  • Hospital Universitari Joan XXIII de Tarragona.

    collaborator OTHER

  • Hospital del Mar

    lead OTHER

Principal Investigators

  • MIGUEL PERA, PhD · Hospital del Mar

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-03-30
Completion
2021-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04851054 on ClinicalTrials.gov